Page 124 - KDU Law Journal Volume 4 Issue 2
P. 124

KDU Law Journal                                  Volume 04 Issue II
                                                              September, 2024
             Introduction
             ‘‘The world needs the vaccine  today-not  tomorrow-to stop the
             disease  and  end  the  pandemic․  We  need  to  embrace  the  access
             to medicine-a  moment  against patent  monopoly  in life-saving
             drugs․’’ 1

             In  the  purview  of  globalization,  everything  is  on  our  fingertips
             However, microscopic  COVID-19 virus was able  to control
             social,  economic  and  political  factors  of the  world. Globally,
             approximately 550 million confirmed cases reported with more than
             six million death rate by 2023 June.  This is a highly contagious
                                              2
             virus, intensely spreads by way of close contacts with an infected
             patient without safety precautions. People were not aware about
             COVID-19 at the beginning and there was no enough access to
             medicines.  Conspicuously, Right  to Patent  imposed  restrictions
             on the Right to Health. Thus, Right to health and Right to patent
             collided  restraining  the interests  of people. This necessitated an
             approach to minimize friction and achieve sustainable development
             while balancing human rights of the people.
             Discussion and Analysis
             Health sector was at the front line during the COVID-19 pandemic
             but there was an inequality  in accessing to health  all around
             the world. According to the Census report of the World Health
             Organization, one third of world population does not have enough
             access to medicines. The development of the Roadmap for Access
             to Medicines, Vaccines, and Health Products was done in order
             to illustrate the work that needs to be done at every stage of the
             value  chain.  These  steps include  the  development  of clinical
             and epidemiological  research, selection  procedures, regulatory

             1 Xiaodong Yuan, Xiaotao Li, Pledging Patent Rights for Fighting Against the COVID-19:
             From the Ethical and Efciency Perspective,( Springer Nature, 17 June 2021) https;//ww-
             wright=to=health=and=patent=right=during=covid=19 access on 10  July 2021
                                                         th
             2   “World  Health  Organization”  2023  May 11,  Weekly  epidemiological  update  on
             COVID19  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-
             covid-19---11-may-2023 access on 16th May 2023
                                                             law.faculty@kdu.ac.lk
                                         117
   119   120   121   122   123   124   125   126   127   128   129